Anika Therapeutics, Inc. (ANIK)
14.12
-0.13
(-0.91%)
USD |
NASDAQ |
Mar 06, 16:00
14.05
-0.07
(-0.50%)
After-Hours: 20:00
Anika Therapeutics SG&A Expense (TTM) : 49.09M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 348.65M |
| Lantheus Holdings, Inc. | 453.81M |
| TELA Bio, Inc. | 78.15M |
| Plus Therapeutics, Inc. | 11.09M |
| BioStem Technologies, Inc. | 206.49M |